129 related articles for article (PubMed ID: 28688688)
1. Survival after refusal of surgical treatment for locally advanced laryngeal cancer.
Massa ST; Osazuwa-Peters N; Franco J; Ward GW; Walker RJ
Oral Oncol; 2017 Aug; 71():34-40. PubMed ID: 28688688
[TBL] [Abstract][Full Text] [Related]
2. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
4. [Results of total laryngectomy as treatment for locally advanced laryngeal cancer in the organ-preservation era].
Rodrigo JP; López F; Llorente JL; Álvarez-Marcos C; Suárez C
Acta Otorrinolaringol Esp; 2015; 66(3):132-8. PubMed ID: 25103645
[TBL] [Abstract][Full Text] [Related]
5. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
[TBL] [Abstract][Full Text] [Related]
6. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
Chen AY; Fedewa S; Zhu J
Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
[TBL] [Abstract][Full Text] [Related]
8. Refusal of curative radiation therapy and surgery among patients with cancer.
Aizer AA; Chen MH; Parekh A; Choueiri TK; Hoffman KE; Kim SP; Martin NE; Hu JC; Trinh QD; Nguyen PL
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):756-64. PubMed ID: 24803037
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.
Lin CC; Fedewa SA; Prickett KK; Higgins KA; Chen AY
Cancer; 2016 Sep; 122(18):2845-56. PubMed ID: 27243553
[TBL] [Abstract][Full Text] [Related]
11. Refusal of Cancer-Directed Surgery in Head and Neck Squamous Cell Carcinoma Patients.
Crippen MM; Elias ML; Weisberger JS; Brady JS; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Jun; 129(6):1368-1373. PubMed ID: 30070700
[TBL] [Abstract][Full Text] [Related]
12. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
Zhu J; Fedewa S; Chen AY
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
[TBL] [Abstract][Full Text] [Related]
13. Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer.
Yabuki K; Sano D; Shiono O; Arai Y; Chiba Y; Tanabe T; Nishimura G; Takahashi M; Taguchi T; Kaneta T; Hata M; Oridate N
Laryngoscope; 2017 Apr; 127(4):862-867. PubMed ID: 27576793
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients.
Shin JY; Truong MT
Laryngoscope; 2015 Jul; 125(7):1667-74. PubMed ID: 25694265
[TBL] [Abstract][Full Text] [Related]
15. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy.
Gorphe P; Matias M; Blanchard P; Even C; Ferte C; Tao Y; Temam S; Bidault F; Janot F
Laryngoscope; 2017 Aug; 127(8):1791-1796. PubMed ID: 27888508
[TBL] [Abstract][Full Text] [Related]
17. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
18. Harmful impact of treatment refusal in T3-4M0 endolaryngeal squamous cell carcinoma candidates for total laryngectomy: A STROBE analysis.
Laccourreye O; Gervais C; Garcia D; Amiri G; Mirghani H; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Sep; 140(5):221-225. PubMed ID: 37321906
[TBL] [Abstract][Full Text] [Related]
19. Persistent racial disparities in refusal of resection in non-small cell lung cancer patients at high-volume and Black-serving institutions.
Coaston TN; Sakowitz S; Chervu NL; Branche C; Shuch BM; Benharash P; Revels S
Surgery; 2023 Dec; 174(6):1428-1435. PubMed ID: 37821266
[TBL] [Abstract][Full Text] [Related]
20. Improvements in survival and disparities for advanced-stage laryngeal cancer.
LeBlanc BJ; Shi R; Mehta V; Mills G; Ampil F; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):169-73. PubMed ID: 25429594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]